| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients
|
Bent-Ennakhil, Nawal
|
|
2017
|
6 |
1 |
p. 131-144
|
artikel
|
| 2 |
Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database
|
Boster, Aaron
|
|
2017
|
6 |
1 |
p. 91-102
|
artikel
|
| 3 |
Depression Among HIV/AIDS Patients on Highly Active Antiretroviral Therapy in the Southwest Regional Hospitals of Cameroon: A Cross-Sectional Study
|
Ngum, Pleasure Atoh
|
|
2017
|
6 |
1 |
p. 103-114
|
artikel
|
| 4 |
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
|
Malucchi, Simona
|
|
2016
|
6 |
1 |
p. 145-152
|
artikel
|
| 5 |
Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease: Determinants and Level of Change Observed
|
Lacey, Loretto
|
|
2016
|
6 |
1 |
p. 11-23
|
artikel
|
| 6 |
Natalizumab for Achieving Relapse-Free, T1 Gadolinium-Enhancing-Lesion-Free, and T2 Lesion-Free Status in Japanese Multiple Sclerosis Patients: A Phase 2 Trial Subanalysis
|
Saida, Takahiko
|
|
2017
|
6 |
1 |
p. 153-159
|
artikel
|
| 7 |
Number Needed to Treat in Multiple Sclerosis Clinical Trials
|
Okwuokenye, Macaulay
|
|
2017
|
6 |
1 |
p. 1-9
|
artikel
|
| 8 |
Prescription Patterns of Medications for Alzheimer’s Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database Study
|
Kadohara, Kimiko
|
|
2016
|
6 |
1 |
p. 25-37
|
artikel
|
| 9 |
Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS Patients
|
Lee, Andrew
|
|
2017
|
6 |
1 |
p. 79-90
|
artikel
|
| 10 |
Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
|
Dennis, Michael
|
|
2017
|
6 |
1 |
p. 57-77
|
artikel
|
| 11 |
Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial
|
Saida, Takahiko
|
|
2016
|
6 |
1 |
p. 39-55
|
artikel
|
| 12 |
Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study
|
Sikirica, Vanja
|
|
2017
|
6 |
1 |
p. 115-130
|
artikel
|
Tijdschrift beschrijving